Skip to main content
Erschienen in: Annals of Hematology 6/2014

01.06.2014 | Original Article

A 30-year epidemiologic survey (1974–2003) of haematological malignancies on the island of Sardinia: temporal changes in incidence and a geographic comparison of incidence rates

verfasst von: G. Broccia, M. Longinotti, A. Gabbas, Caterina Porcu, E. Chessa, Barbara Giannico

Erschienen in: Annals of Hematology | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

In a previous survey of newly diagnosed haematological malignancies (HMs) in Sardinia from 1974 to 1993, we observed a marked increase in the incidence of many HMs that we chiefly attributed to improvements in case ascertainment. To better define the nature of this increase, we extended the survey by an additional decade (1994–2003), applying the same previously used methods. The incidence of HMs further increased from 1994 to 2003. The incidence rate of total HMs (THMs), standardised to the world population, was 30.15 × 105 person-years vs. 21.58 from 1984 to 1993 and 15.26 from 1974 to 1983. The temporal variations in the incidence differed in different HMs and were correlated with the diseases clinical characteristics and the increased availability of diagnostic tools and skills in Sardinia. These observations support the hypothesis that the temporal differences in the incidence rates observed for many HMs in Sardinia over the 30-year survey period were caused by temporal differences in diagnostic efficiency rather than by disease occurrence. An important exception was the increase in non-Hodgkin’s lymphoma, which represents a true increase in occurrence, similarly to most Western countries. The incidence rates of HMs already having or reaching stable values in the decade 1994–2003 were similar to those of most Western countries. No significant evidence emerged to suggest that Sardinian particularities influenced the occurrence of HMs. This study demonstrates the extent to which diagnostic efficiency can influence incidence evaluations and emphasises the importance of prolonged observation to determine the validity of incidence rates for both temporal and geographic comparisons.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Bernardinelli L, Maida A, Marinoni A, Clayton DG, Romano G, Montomoli C, Fadda D, Solinas G, Castiglia P, Cocco PI, Ghislandi M, Berzuini C, Pascutto C, Nerini M, Styles B, Capocaccia R, Lispi L, Mallardo E (1994) Atlas of cancer mortality in Sardinia 1983–1987. Direzione Progetto FATMA CNR, Rome Bernardinelli L, Maida A, Marinoni A, Clayton DG, Romano G, Montomoli C, Fadda D, Solinas G, Castiglia P, Cocco PI, Ghislandi M, Berzuini C, Pascutto C, Nerini M, Styles B, Capocaccia R, Lispi L, Mallardo E (1994) Atlas of cancer mortality in Sardinia 1983–1987. Direzione Progetto FATMA CNR, Rome
2.
Zurück zum Zitat Biggeri A, Lagazio C, Catelan D, Pirastu R, Casson E, Terracini B (2006) Report on health status of residents in areas with industrial, mining or military sites in Sardinia, Italy. Epidemiol Prev 30(1 Suppl 1):5–95PubMed Biggeri A, Lagazio C, Catelan D, Pirastu R, Casson E, Terracini B (2006) Report on health status of residents in areas with industrial, mining or military sites in Sardinia, Italy. Epidemiol Prev 30(1 Suppl 1):5–95PubMed
3.
Zurück zum Zitat Broccia G, Deplano W, Dessalvi P, Giannico B, Luxi G, Chessa E, Murru A (2004) Haematological malignancies in the island of Sardinia 1974–1993: age and sex distributions and temporal changes in incidence. Hematol Oncol 22:91–109PubMedCrossRef Broccia G, Deplano W, Dessalvi P, Giannico B, Luxi G, Chessa E, Murru A (2004) Haematological malignancies in the island of Sardinia 1974–1993: age and sex distributions and temporal changes in incidence. Hematol Oncol 22:91–109PubMedCrossRef
4.
Zurück zum Zitat Centers for Disease Control and Prevention (2003) Epi Info 2002 software, revision 2. Centers for Disease Control and Prevention. Atlanta, GA Centers for Disease Control and Prevention (2003) Epi Info 2002 software, revision 2. Centers for Disease Control and Prevention. Atlanta, GA
5.
Zurück zum Zitat Plummer M (1977) Age standardization. In: Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (eds) Cancer incidence in five continents, vol. 7. IARC, Lyon, pp 66–68 Plummer M (1977) Age standardization. In: Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (eds) Cancer incidence in five continents, vol. 7. IARC, Lyon, pp 66–68
6.
Zurück zum Zitat Smith A, Howell D, Patmore R, Jack A, Roman E (2011) Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network. Br J Cancer 105:1684–1692PubMedCentralPubMedCrossRef Smith A, Howell D, Patmore R, Jack A, Roman E (2011) Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network. Br J Cancer 105:1684–1692PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Sant M, Allemani C, Tereanu C, De Angelis R, Capocaccia R, Visser O, Marcos-Gragera R, Maynadié M, Simonetti A, Lutz JM, Berrino F (2010) Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood 116:3724–3734PubMedCrossRef Sant M, Allemani C, Tereanu C, De Angelis R, Capocaccia R, Visser O, Marcos-Gragera R, Maynadié M, Simonetti A, Lutz JM, Berrino F (2010) Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood 116:3724–3734PubMedCrossRef
8.
Zurück zum Zitat Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS (2006) Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood 107:265–277PubMedCentralPubMedCrossRef Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS (2006) Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood 107:265–277PubMedCentralPubMedCrossRef
10.
Zurück zum Zitat Xie Y, Davies SM, Xiang Y, Robinson LL, Ross JA (2003) Trends in leukemia incidence and survival in the United States (1973–1998). Cancer 97:2229–2235PubMedCrossRef Xie Y, Davies SM, Xiang Y, Robinson LL, Ross JA (2003) Trends in leukemia incidence and survival in the United States (1973–1998). Cancer 97:2229–2235PubMedCrossRef
11.
Zurück zum Zitat McNally RJ, Roman E, Cartwright RA (1999) Leukemias and lymphomas: time trends in the UK, 1984–93. Cancer Causes Control 10:35–42PubMedCrossRef McNally RJ, Roman E, Cartwright RA (1999) Leukemias and lymphomas: time trends in the UK, 1984–93. Cancer Causes Control 10:35–42PubMedCrossRef
13.
Zurück zum Zitat Maynadié M, Girodon F, Manivet-Janoray I, Mounier M, Mugneret F, Bailly F, Favre B, Caillot D, Petrella T, Flesch M, Carli PM (2011) Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematological malignancies of Cote d’Or (Burgundy, France). Haematologica 96:55–61PubMedCentralPubMedCrossRef Maynadié M, Girodon F, Manivet-Janoray I, Mounier M, Mugneret F, Bailly F, Favre B, Caillot D, Petrella T, Flesch M, Carli PM (2011) Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematological malignancies of Cote d’Or (Burgundy, France). Haematologica 96:55–61PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Devesa SS, Fears T (1992) Non-Hodgkin’s lymphoma time trends: United States and international data. Cancer Res 52:5432s–5440sPubMed Devesa SS, Fears T (1992) Non-Hodgkin’s lymphoma time trends: United States and international data. Cancer Res 52:5432s–5440sPubMed
16.
Zurück zum Zitat Carli PM, Boutron MC, Maynadie M, Bailly F, Caillot D, Petrella T (1994) Increase in the incidence of non-Hodgkin’s lymphomas: evidence for a recent sharp increase in France independent of AIDS. Br J Cancer 70:713–715PubMedCentralPubMedCrossRef Carli PM, Boutron MC, Maynadie M, Bailly F, Caillot D, Petrella T (1994) Increase in the incidence of non-Hodgkin’s lymphomas: evidence for a recent sharp increase in France independent of AIDS. Br J Cancer 70:713–715PubMedCentralPubMedCrossRef
17.
Zurück zum Zitat Muller AMS, Ihorst G, Mertelsmann R, Engelhardt M (2005) Epidemiology of non-Hodgkin’s lymphoma (NHL): trends, geographic distribution and etiology. Ann Hematol 84:1–12PubMedCrossRef Muller AMS, Ihorst G, Mertelsmann R, Engelhardt M (2005) Epidemiology of non-Hodgkin’s lymphoma (NHL): trends, geographic distribution and etiology. Ann Hematol 84:1–12PubMedCrossRef
18.
Zurück zum Zitat Alexander DD, Mink PJ, Adami HO, Chang ET, Cole P, Mandel JS, Trichopoulos D (2007) The non-Hodgkin lymphomas: a review of the epidemiological literature. Int J Cancer 120:1–39PubMedCrossRef Alexander DD, Mink PJ, Adami HO, Chang ET, Cole P, Mandel JS, Trichopoulos D (2007) The non-Hodgkin lymphomas: a review of the epidemiological literature. Int J Cancer 120:1–39PubMedCrossRef
19.
Zurück zum Zitat Dores GM, Anderson WF, Curtis RE, Landgren O, Ostroumova E, Bluhm EC, Rabkin CS, Devesa SS, Linet MS (2007) Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology. Br J Haematol 139:809–819PubMedCrossRef Dores GM, Anderson WF, Curtis RE, Landgren O, Ostroumova E, Bluhm EC, Rabkin CS, Devesa SS, Linet MS (2007) Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology. Br J Haematol 139:809–819PubMedCrossRef
20.
Zurück zum Zitat van den Broek EC, Kater AP, van de Schans SA, Karim-Kos HE, Janssen-Heijnen ML, Peters WG, Nooijen PT, Coebergh JW, Posthuma EF (2012) Chronic lymphocytic leukaemia in the Netherlands: trends in incidence, treatment and survival. Eur J Cancer 48:889–895PubMedCrossRef van den Broek EC, Kater AP, van de Schans SA, Karim-Kos HE, Janssen-Heijnen ML, Peters WG, Nooijen PT, Coebergh JW, Posthuma EF (2012) Chronic lymphocytic leukaemia in the Netherlands: trends in incidence, treatment and survival. Eur J Cancer 48:889–895PubMedCrossRef
21.
Zurück zum Zitat Turesson I, Velez R, Kristinsson SY, Landgren O (2010) Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinic. Mayo Clin Proc 85:225–230PubMedCentralPubMedCrossRef Turesson I, Velez R, Kristinsson SY, Landgren O (2010) Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinic. Mayo Clin Proc 85:225–230PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Jensen MK, de Nully BP, Nielsen OJ, Hasselbach HC (2000) Incidence, clinical features and outcome of essential thrombocythaemia in a well-defined geographical area. Eur J Haematol 65:132–139PubMedCrossRef Jensen MK, de Nully BP, Nielsen OJ, Hasselbach HC (2000) Incidence, clinical features and outcome of essential thrombocythaemia in a well-defined geographical area. Eur J Haematol 65:132–139PubMedCrossRef
23.
Zurück zum Zitat Rollison DE, Howlader N, Smith MT, Strom SS, Merritt WD, Ries LA, Edwards BK, List AF (2008) Epidemiology of myelodisplastic syndromes and chronic myeloprolipherative disorders in the United States, 2001–2004, using data from the NAACCR and SEER programs. Blood 112:45–52PubMedCrossRef Rollison DE, Howlader N, Smith MT, Strom SS, Merritt WD, Ries LA, Edwards BK, List AF (2008) Epidemiology of myelodisplastic syndromes and chronic myeloprolipherative disorders in the United States, 2001–2004, using data from the NAACCR and SEER programs. Blood 112:45–52PubMedCrossRef
Metadaten
Titel
A 30-year epidemiologic survey (1974–2003) of haematological malignancies on the island of Sardinia: temporal changes in incidence and a geographic comparison of incidence rates
verfasst von
G. Broccia
M. Longinotti
A. Gabbas
Caterina Porcu
E. Chessa
Barbara Giannico
Publikationsdatum
01.06.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Annals of Hematology / Ausgabe 6/2014
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-013-2002-z

Weitere Artikel der Ausgabe 6/2014

Annals of Hematology 6/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.